In limited data it's generally reported as well-tolerated, but human safety data is still limited and long-term effects aren't fully characterized
While the same is yet to be proven in clinical settings, there have been informal recommendations for 5-amino-1MQ dosing, proposing a daily dosage ranging from 50mg to 150mg, administered orally
Observed effects in human trials Reported adverse events across the IV and oral trials included headache, fatigue, dizziness, nasopharyngitis, diarrhea, flatulence, increased appetite, nausea, and back pain
CONCLUSION In conclusion, vitamin B12 deficiency management involves various administration routes, including intramuscular (IM), oral, and subcutaneous methods
This dose usually keeps B12 levels good for most patients